Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
For Use With (Application)
- (2)
- (2,347)
- (79)
- (3)
- (1)
- (1)
- (2)
- (354)
- (6,099)
- (7)
- (2)
- (7)
- (2)
- (1)
- (1)
- (2)
- (6)
- (41)
- (2)
- (2)
- (2)
- (2)
- (1)
- (2)
- (3)
- (1)
- (157)
- (1)
- (3)
- (1)
- (5)
- (10)
- (26,072)
- (1)
- (2)
- (1)
- (21)
- (1)
- (12,637)
- (1,160)
- (2)
- (2)
- (8)
- (1)
- (110)
- (8)
- (2)
- (1)
- (8)
- (1)
- (1)
- (1)
- (44)
- (256)
- (158)
- (1)
- (7)
- (1)
- (1)
- (3)
- (4)
- (1)
- (11,340)
- (25)
- (3)
- (30)
- (14)
- (15)
- (73)
- (13)
- (76)
- (78)
- (34)
- (2)
- (13)
- (1)
- (1,154)
- (2)
- (157)
- (26)
- (8)
- (1)
- (2)
- (2)
- (1)
- (18)
- (2)
- (21,642)
- (2,889)
- (4)
- (1)
- (2,842)
- (4)
- (7)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (11,319)
- (3)
- (6)
- (1)
- (1)
- (6)
- (7)
- (5)
- (1)
- (6)
- (1)
- (5,573)
- (6)
- (4)
- (3)
- (12)
- (2)
- (4)
- (5)
- (4)
- (6)
- (1)
- (13,022)
- (1,867)
- (1)
- (1)
Conjugate
- (11)
- (1)
- (4)
- (2)
- (9)
- (8)
- (1)
- (24)
- (1)
- (3)
- (1)
- (1)
- (3)
- (2)
- (1)
- (9)
- (2)
- (1)
- (13)
- (5)
- (1)
- (2)
- (3)
- (35,877)
Recombinant
- (70)
- (34,775)
Form
- (1)
- (1)
- (23,086)
- (9,225)
- (29)
- (146)
- (26)
- (35)
Regulatory Status
- (79)
- (30,568)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Search Within Results
Keyword Search:
Clear All
1
–
15
of
40,138
results
R&D Systems™ Recombinant Human HO-2/HMOX2 Protein
A Novus product, part of R&D Systems. Highly purified. Generating reliable and reproducible results.
Invitrogen™ eBioscience™ Concanavalin A (Con A) Solution (500X)
The Concanavalin A (Con A) Solution (500X) is a ready-to-use solution of Con A in aqueous buffer.
| Format | Vial |
|---|---|
| Form | Solution |
| Source | Canavlia Ensiformis |
| Product Line | eBioscience |
| Protein Subtype | Lectins |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | CXCL12 alpha |
| Molecular Weight (g/mol) | 8 kDa |
| Gene Symbol | CXCL12 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | KPVSLSYRCP CRFFESHVAR ANVKHLKILN TPNCALQIVA RLKNNNRQVC IDPKLKWIQE YLEKALNK |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human CXCL12 (SDF-1a) |
| Accession Number | P48061 |
| Gene Alias | 12-O-tetradecanoylphorbol 13-acetate repressed protein 1; C Cmotif chemokine; C X C motif chemokine; CC motif chemokine; CCmotif chemokine; chemokine (C-X-C motif) ligand 12; chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1); CXC; CXC motif chemokine; C-X-C motif chemokine 12; C-X-C motif chemokine ligand 12; CXCL; Cxcl12; H-SDF-1-alpha; Intercrine reduced in hepatomas; IRH; Pbsf; pre-B cell growth-stimulating factor; pre-B-cell growth-stimulating factor; SCYB12; SDF 1 a; SDF 1 alpha; SDF 1α; SDF1; SDF-1; SDF1 alpha; SDF-1 gamma; SDF1A; SDF-1-alpha(3-67); SDF1B; SDF-1-beta(3-72); SDF1α; Stromal cell-derived factor 1; stromal cell-derived factor-1 alpha; stromal cell-derived factor-1 gamma; thymic lymphoma cell-stimulating factor; TLSF; Tpar1 |
| Biological Activity | Determined by its ability to chemoattract IL-2-activated human T cells using a concentration range of 20.0-80.0 ng/ml |
| Gene ID (Entrez) | 6387 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥ 97% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 26 kDa |
| Common Name | Activin A |
| Gene Symbol | Inhba |
| Activity | The ED50 as determined by its ability to inhibit the proliferation of murine MPC-11 cells is ≤ 2.0 ng/ml, corresponding to a specific activity of ≥ 5 x 10^5 units/mg. |
| Endotoxin Concentration | <1 EU/μg |
| Storage Requirements | -20°C |
| Sequence | GLECDGKVNI CCKKQFFVSF KDIGWNDWII APSGYHANYC EGECPSHIAG TSGSSLSFHS TVINHYRMRG HSPFANLKSC CVPTKLRPMS MLYYDDGQNI IKKDIQNMIV EECGCS |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity,Control |
| Name | Human/Mouse/Rat Activin A |
| Accession Number | P08476, P18331, Q04998 |
| Purification Method | Purified |
| Gene Alias | activin A; activin beta-A chain; BMP7; BMP-7; Bone morphogenetic protein 7; EDF; Eptotermin alfa; erythroid differentiation factor; erythroid differentiation protein; follicle-stimulating hormone-releasing protein; FRP; FSH-releasing protein; INHB; Inhba; inhibin B subunit; inhibin beta A chain; inhibin beta A protein; inhibin beta A subunit; inhibin beta-A; inhibin beta-A-subunit; inhibin beta-subunit; inhibin subunit beta A; inhibin, beta A; inhibin, beta A (activin A, activin AB alpha polypeptide); Inhibin, beta-1; OP1; OP-1; Osteogenic protein 1; unnamed protein product |
| Product Type | Protein |
| Gene ID (Entrez) | 16323, 29200, 3624 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | Prolactin |
| Molecular Weight (g/mol) | 23 kDa |
| Gene Symbol | PRL |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MLPICPGGAA RCQVTLRDLF DRAVVLSHYI HNLSSEMFSE FDKRYTHGRG FITKAINSCH TSSLATPEDK EQAQQMNQKD FLSLIVSILR SWNEPLYHLV TEVRGMQEAP EAILSKAVEI EEQTKRLLEG MELIVSQVHP ETKENEIYPV WSGLPSLQMA DEESRLSAYY NLLHCLRRDS HKIDNYLKLL KCRIIHNNNC |
| Expression System | E. coli |
| For Use With (Application) | Control,Bioactivity |
| Source | E. coli |
| Name | Human Prolactin |
| Accession Number | P01236 |
| Gene Alias | AV290867; decidual prolactin; GHA1; growth hormone A1; Human prolactin; lactogenic prehormone (AA -30 to 199); preprolactin; pre-prolactin; Prl; Prl1a1; PRLB; PRLSD1; Prol; Prolactin; prolactin family 1, subfamily a, member 1; prolactin precursor; prolactin protein; RATPRLSD1; RNPROL |
| Biological Activity | Determined by its ability to induce the proliferation of rat Nb2-11 cells in the concentration range of 0.1-1.0 ng/ml |
| Gene ID (Entrez) | 5617 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6.2 kDa |
| Gene Symbol | EGF |
| Endotoxin Concentration | <0.1 EU/μg |
| Sequence | NSDSECPLSH DGYCLHDGVC MYIEALDKYA CNCVVGYIGE RCQYRDLKWW ELR |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human EGF, Animal-Free |
| Accession Number | P01133 |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Biological Activity | The ED50 was determined by a cell proliferation assay using balb/c 3T3 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 1950 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Protein Family | Growth Factors & Receptors |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | TGF beta-1 |
| Molecular Weight (g/mol) | 25 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Gene Symbol | Tgfb1 |
| Endotoxin Concentration | <0.1 ng/μg |
| For Use With (Application) | Bioactivity |
| Protein Subtype | TGFs (Transforming Growth Factors) |
| Name | Human TGF-beta 1 |
| Accession Number | P01137 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | CED; cytokine; DPD1; LAP; Latency-associated peptide; prepro-transforming growth factor beta-1; regulatory protein; TGF b; TGF b 1; TGF beta; tgf beta 1; tgf beta1; TGF beta-1; TGF beta-1 protein; TGF β; TGF β 1; TGF β1; Tgfb; TGFB1; TGF-B1; Tgfb-1; TGFbeta; TGF-beta 1; TGF-beta 1 protein; TGFbeta1; TGF-beta1; TGF-beta-1; TGFβ1; Transforming growth factor; transforming growth factor b1; transforming growth factor beta; transforming growth factor beta 1; transforming growth factor beta-1; Transforming growth factor beta-1 proprotein; transforming growth factor beta-1 proprotein; transforming growth factor beta-1; transforming growth factor β1; transforming growth factor, beta 1; transforming growth factor, beta 1 (Camurati-Engelmann disease); transforming growth factor, beta-1; transforming growth factor-beta 1; transforming growth factor-beta I; transforming growth factor-beta-1; transforming growth factor-beta-1 precursor; unnamed protein product |
| Protein Form | Recombinant, Ligand |
| Product Type | Protein |
| Gene ID (Entrez) | 7040 |
| Research Category | Immunology, Neurobiology, Oncology, Stem Cell Research, Cardiovascular Research, Differentiation, Bone Research |
| Species | Human |
| Product Line | Gibco |
| Recombinant | Recombinant |
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 23.9 kDa |
| Common Name | BMP4 |
| Gene Symbol | BMP4 |
| Activity | Determined by its ability to induce alkaline phosphatase production by ATDC-5 cells. The expected ED50 for this effect is 5-10 ng/ml. |
| Endotoxin Concentration | <1 EU/μg |
| Storage Requirements | -20°C |
| Sequence | KKNKNCRRHS LYVDFSDVGW NDWIVAPPGY QAFYCHGDCP FPLADHLNST NHAIVQTLVN SVNSSIPKAC CVPTELSAIS MLYLDEYDKV VLKNYQEMVV EGCGCR |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity,Control,Western Blot Control |
| Name | Human BMP-4 |
| Accession Number | P12644 |
| Purification Method | Purified |
| Gene Alias | BMP; BMP2B; BMP-2B; Bmp2b1; Bmp2b-1; Bmp4; Bmp-4; BOMPR4A; Bone morphogenetic protein; Bone morphogenetic protein 2B; bone morphogenetic protein 4; bone morphogenetic protein 4 preproprotein; DVR4; Dvr-4; MCOPS6; OFC11; ZYME |
| Product Type | Protein |
| Gene ID (Entrez) | 652 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | FGF2 |
| Molecular Weight (g/mol) | 17.2 kDa |
| Gene Symbol | FGF2 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | AAGSITTLPA LPEDGGSGAF PPGHFKDPKR LYCKNGGFFL RIHPDGRVDG VREKSDPHIK LQLQAEERGV VSIKGVCANR YLAMKEDGRL LASKCVTDEC FFFERLESNN YNTYRSRKYT SWYVALKRTG QYKLGSKTGP GQKAILFLPM SAKS |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human FGF-basic (FGF-2/bFGF) (154 aa) |
| Accession Number | P09038 |
| Gene Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); Fibroblast growth factor basic; HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
| Biological Activity | Determined by a cell proliferation assay using Balb/c 3T3 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 2247 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | ≥98% by SDS-PAGE and HPLC |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IGF1 |
| Molecular Weight (g/mol) | 7.5 kDa |
| Endotoxin Level | <1 EU/ml |
| Activity | ED50 ≤ 2 ng/mL; determined by the dose-dependent proliferation of FDC-P1 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human IGF-I |
| Purification Method | Purified |
| Gene Alias | C730016P09Rik; class 1 insulin-like growth factor I preproprotein; class 2 insulin-like growth factor I preproprotein; H-IGF-1; IBP1; IGF; IGF1; Igf-1; IGF1A; IGFI; Igf-I; IGFIa; IGF-IA; IGF-IB; insulin growth factor-1; Insulin like growth factor; insulin like growth factor 1; insulin-like growth factor 1; insulin-like growth factor 1 (somatomedin C); insulin-like growth factor I; insulin-like growth factor I (somatomedin C); insulin-like growth factor IB; mechano growth factor; MGF; M-IGF-1; OTTHUMP00000195084; prepro-IGF-I; prepro-insulin-like growth factor I; R-IGF-1; somatomedin; Somatomedin C; Somatomedin-C |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 ≤ 2 ng/mL; determined by the dose-dependent proliferation of FDC-P1 cells. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Neurobiology, Drug Development, Oncology, Signal Transduction |
| Species | Human |
| Recombinant | Recombinant |
| Content And Storage | -20°C |
| Bioassay | proliferation of mouse FDC-P1 cells |
| Gene Symbol | IGF1 |
| Sequence | GPETLCGAEL VDALQFVCGD RGFYFNKPTG YGSSSRRAPQ TGIVDECCFR SCDLRRLEMY CAPLKPAKSA |
| Storage Requirements | -20°C |
| Protein Subtype | IGFs (Insulin-Like Growth Factors) |
| Accession Number | P05019 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 3479 |
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6.2 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human EGF |
| Purification Method | Purified |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Stem Cell Research, Oncology |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Gene Symbol | EGF |
| Storage Requirements | 4°C |
| Protein Subtype | EGF (Epidermal Growth Factor) |
| Accession Number | P01133 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 1950 |
| Product Line | Gibco |
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IFN gamma |
| Molecular Weight (g/mol) | 16.8 kDa |
| Gene Symbol | IFNG |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MQDPYVKEAE NLKKYFNAGH SDVADNGTLF LGILKNWKEE SDRKIMQSQI VSFYFKLFKN FKDDQSIQKS VETIKEDMNV KFFNSNKKKR DDFEKLTNYS VTDLNVQRKA IHELIQVMAE LSPAAKTGKR KRSQMLFQGR RASQ |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human IFN-gamma |
| Accession Number | P01579 |
| Gene Alias | BoIFNG; cytokine; EGK_03901; gamma interferon; gamma interferon precursor; gamma-interferon; gamma-interferon precursor (AA -23 to 143); H-IFN-g; IFG; IFI; IFN gamma; IFN γ; Ifng; IFN-g; IFNG2; IFN-gamma; IFN-gamma precursor; IFN-y; IFNγ; Immune interferon; Interferon; interferon gamma; interferon gamma precursor; interferon gamma type 2; Interferon y; Interferon γ; interferon, gamma; interferon-gama; interferon-gamma; Interferon-gamma level; interferon-gamma precursor; Interferonγ; M-IFN-g; R-IFN-g |
| Biological Activity | The ED50 determined by a cytotoxicity assay using HT-29 cells is = 0.05 ng/ml, corresponding to a specific activity of = 2 x 10^7 units/mg |
| Gene ID (Entrez) | 3458 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
